Andrew Saik

Insider Reports History

Entity
Individual
Location
640 Lee Road, Chesterbrook, PA
Signature
/s/ Jason Minio, Attorney-in-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Andrew Saik:

Stock Role Class Num Shares Value Price $ Report Date Ownership
ARVINAS, INC. Chief Financial Officer Common Stock 61.4K $2.89M $47.05 Jun 24, 2024 Direct
ARVINAS, INC. Chief Financial Officer Stock Option (right to buy) 94.4K $1.51M $16.00 Jun 24, 2024 Direct
VYNE Therapeutics Inc. Chief Financial Officer Common Stock 116K $266K $2.28 May 28, 2021 Direct
Milestone Pharmaceuticals Inc. Director Stock Option (right to buy) 40K Aug 28, 2024 Direct
INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Financial Officer Common Stock 0 $19.00 Nov 8, 2023 Direct
INTERCEPT PHARMACEUTICALS, INC. EVP & Chief Financial Officer Option to Purchase Common Stock 0 Nov 8, 2023 Direct

Insider Reports Filed by Andrew Saik

Symbol Company Period Transactions Value $ Form Type Date Filed Role
MIST Milestone Pharmaceuticals Inc. Aug 28, 2024 1 $0 4 Aug 29, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jul 15, 2024 1 $0 4 Jul 17, 2024 Director
MIST Milestone Pharmaceuticals Inc. Jul 15, 2024 0 $0 3 Jul 17, 2024 Director
ARVN ARVINAS, INC. Jun 24, 2024 2 $0 4 Jun 26, 2024 Chief Financial Officer
ARVN ARVINAS, INC. Jun 24, 2024 0 $0 3 Jun 26, 2024 Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Nov 8, 2023 5 -$1.3M 4 Nov 13, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 21, 2023 1 -$9.81K 4 Sep 25, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2023 1 -$10.7K 4 Jun 23, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Mar 21, 2023 1 -$12.9K 4 Mar 23, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jan 27, 2023 2 $0 4 Jan 31, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Dec 31, 2022 1 -$8.88K 4 Jan 3, 2023 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Dec 21, 2022 1 -$12.2K 4 Dec 23, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Sep 21, 2022 1 -$13.5K 4 Sep 23, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2022 1 -$45.3K 4 Jun 23, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jan 27, 2022 2 $0 4 Jan 31, 2022 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2021 2 $0 4 Jun 22, 2021 EVP & Chief Financial Officer
ICPT INTERCEPT PHARMACEUTICALS, INC. Jun 21, 2021 0 $0 3 Jun 22, 2021 EVP & Chief Financial Officer
VYNE VYNE Therapeutics Inc. May 28, 2021 1 $10.1K 4 Jun 2, 2021 Chief Financial Officer